BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30084963)

  • 1. Interrogating the Relationship Between Schizotypy, the Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism, and Neuronal Oscillatory Activity.
    Steiner GZ; Fernandez FM; Coles M; Karamacoska D; Barkus E; Broyd SJ; Solowij N; Watson OT; Chiu CL; Lind JM; Barry RJ
    Cereb Cortex; 2019 Jul; 29(7):3048-3058. PubMed ID: 30084963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population.
    Ma X; Sun J; Yao J; Wang Q; Hu X; Deng W; Sun X; Liu X; Murray RM; Collier DA; Li T
    Psychiatry Res; 2007 Sep; 153(1):7-15. PubMed ID: 17604122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men.
    Smyrnis N; Avramopoulos D; Evdokimidis I; Stefanis CN; Tsekou H; Stefanis NC
    Biol Psychiatry; 2007 Apr; 61(7):845-53. PubMed ID: 17123481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele.
    Avramopoulos D; Stefanis NC; Hantoumi I; Smyrnis N; Evdokimidis I; Stefanis CN
    Mol Psychiatry; 2002; 7(7):706-11. PubMed ID: 12192614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele.
    Schürhoff F; Szöke A; Chevalier F; Roy I; Méary A; Bellivier F; Giros B; Leboyer M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):64-8. PubMed ID: 17034018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of COMT val158met genotype on cognition and personality.
    Sheldrick AJ; Krug A; Markov V; Leube D; Michel TM; Zerres K; Eggermann T; Kircher T
    Eur Psychiatry; 2008 Sep; 23(6):385-9. PubMed ID: 18755576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia.
    Docherty AR; Sponheim SR
    J Abnorm Psychol; 2008 Nov; 117(4):788-98. PubMed ID: 19025226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of catechol-O-methyl-transferase polymorphism Val158Met on functional connectivity in healthy young females: a resting EEG study.
    Lee TW; Yu YW; Hong CJ; Tsai SJ; Wu HC; Chen TJ
    Brain Res; 2011 Mar; 1377():21-31. PubMed ID: 21195697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults.
    Meyer BM; Huemer J; Rabl U; Boubela RN; Kalcher K; Berger A; Banaschewski T; Barker G; Bokde A; Büchel C; Conrod P; Desrivières S; Flor H; Frouin V; Gallinat J; Garavan H; Heinz A; Ittermann B; Jia T; Lathrop M; Martinot JL; Nees F; Rietschel M; Smolka MN; Bartova L; Popovic A; Scharinger C; Sitte HH; Steiner H; Friedrich MH; Kasper S; Perkmann T; Praschak-Rieder N; Haslacher H; Esterbauer H; Moser E; Schumann G; Pezawas L
    Brain Struct Funct; 2016 Jan; 221(1):103-14. PubMed ID: 25319752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT-by-sex interaction effect on psychosis proneness.
    de Castro-Catala M; Barrantes-Vidal N; Sheinbaum T; Moreno-Fortuny A; Kwapil TR; Rosa A
    Biomed Res Int; 2015; 2015():829237. PubMed ID: 25722988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
    Dauvilliers Y; Tafti M; Landolt HP
    Sleep Med Rev; 2015 Aug; 22():47-53. PubMed ID: 25466290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.
    Silberschmidt AL; Sponheim SR
    Schizophr Res; 2008 Mar; 100(1-3):316-24. PubMed ID: 18201871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.
    Lee YH; Kim JH; Song GG
    Rheumatol Int; 2015 Jan; 35(1):159-66. PubMed ID: 24951880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.
    Hori H; Fujii T; Yamamoto N; Teraishi T; Ota M; Matsuo J; Kinoshita Y; Ishida I; Hattori K; Okazaki M; Arima K; Kunugi H
    J Psychiatr Res; 2014 Sep; 56():82-9. PubMed ID: 24888672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
    Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction Between Val158Met Catechol-O-Methyltransferase Polymorphism and Social Cognitive Functioning in Schizophrenia: Pilot Study.
    Tylec A; Jeleniewicz W; Mortimer A; Bednarska-Makaruk M; Kucharska K
    Ann Hum Genet; 2017 Nov; 81(6):267-275. PubMed ID: 28856668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.